122 related articles for article (PubMed ID: 7923104)
1. Evaluation of toxicity of cypenhymustine, a new anticancer compound, in mice.
Sadhu U; Ghosh M; Bhattacharya S; Dutta S; Das H; Sanyal U
Cancer Lett; 1994 Sep; 85(1):65-72. PubMed ID: 7923104
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of toxicity of beta-tethymustine, a new anticancer compound, in mice.
Ghosh M; Sadhu U; Bhattacharya S; Dutta S; Bhattacharya B; Sanyal U
Cancer Lett; 1999 Apr; 138(1-2):107-14. PubMed ID: 10378781
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of 'cypenhymustine', a new anticancer compound, in murine tumour models.
Sanyal U; Bhattacharya S; Sadhu U; Dutta S; Das H; Ghosh M
Cancer Lett; 1993 Jun; 70(1-2):1-6. PubMed ID: 8330289
[TBL] [Abstract][Full Text] [Related]
4. In vivo effect of recombinant human leukemia inhibitory factor in primates.
Akiyama Y; Kajimura N; Matsuzaki J; Kikuchi Y; Imai N; Tanigawa M; Yamaguchi K
Jpn J Cancer Res; 1997 Jun; 88(6):578-83. PubMed ID: 9263535
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of kidney and liver subacute toxicity of antitumor agents using serum biochemical parameters in rats.
Pispirigos K; Catsoulakos P; Karakiulakis G
Biochem Mol Biol Int; 1993 Nov; 31(3):565-73. PubMed ID: 7906982
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of naphthalmustine, a nitrogen mustard derivative of naphthalimide as a rationally-designed anticancer agent.
Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Kampasi H; Qazi GN; Sanyal U
J Exp Clin Cancer Res; 2003 Sep; 22(3):411-8. PubMed ID: 14582700
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of phthalmustine, a new anticancer compound. II. Tumor inhibitory effect in murine Ehrlich ascites carcinoma and sarcoma-180.
Bhattacharya S; Ghosh M; Sadhu U; Dutta S; Sanyal U
Neoplasma; 1996; 43(3):209-13. PubMed ID: 8841510
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of antitumor efficacy and toxicity of novel 6-nitro-2-(3-chloropropyl)-1H-benz[de]isoquinoline-1,3-dione in vivo in mouse.
Mukherjee A; Dutta S; Sanyal U
J Cancer Res Ther; 2013; 9(3):442-6. PubMed ID: 24125980
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of phthalmustine, a new anticancer compound. I. Effect on Dalton's ascitic lymphoma in mice.
Bhattacharya S; Ganguly C; Sanyal U; Das S
Neoplasma; 1994; 41(1):35-8. PubMed ID: 8202193
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of naphthal-NU, a 2-chloroethylnitrosourea derivative of naphthalimide, as a mixed-function anticancer agent.
Samanta S; Pain A; Dutta S; Sanyal U
J Exp Clin Cancer Res; 2002 Mar; 21(1):87-93. PubMed ID: 12071535
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of dimethoxydop-NU as a novel anti-tumor agent.
Mukherjee A; Dutta S; Sanyal U
J Exp Clin Cancer Res; 2007 Dec; 26(4):489-97. PubMed ID: 18365543
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of fluoren-NU as a novel antitumor agent.
Mukherjee A; Dutta S; Chashoo G; Bhagat M; Saxena AK; Sanyal U
Oncol Res; 2009; 17(9):387-96. PubMed ID: 19718945
[TBL] [Abstract][Full Text] [Related]
13. Ameliorative effect of riboflavin on the cisplatin induced nephrotoxicity and hepatotoxicity under photoillumination.
Hassan I; Chibber S; Naseem I
Food Chem Toxicol; 2010; 48(8-9):2052-8. PubMed ID: 20457210
[TBL] [Abstract][Full Text] [Related]
14. Protective role of Ginkgo biloba against hepatotoxicity and nephrotoxicity in uranium-treated mice.
Yapar K; Cavuşoğlu K; Oruç E; Yalçin E
J Med Food; 2010 Feb; 13(1):179-88. PubMed ID: 20136453
[TBL] [Abstract][Full Text] [Related]
15. Studies on poly I:C toxicity in experimental animals.
Homan ER; Zendzian RP; Schott LD; Levy HB; Adamson RH
Toxicol Appl Pharmacol; 1972 Dec; 23(4):579-88. PubMed ID: 4630165
[No Abstract] [Full Text] [Related]
16. In vivo anti-tumour activity of novel Quinazoline derivatives.
Alapati V; Noolvi MN; Manjula SN; Pallavi KJ; Patel HM; Tippeswamy BS; Satyanarayana SV
Eur Rev Med Pharmacol Sci; 2012 Nov; 16(13):1753-64. PubMed ID: 23208959
[TBL] [Abstract][Full Text] [Related]
17. Histological vis-a-vis biochemical assessment on the toxic level and antineoplastic efficacy of a synthetic drug Pt-ATP on experimental animal models.
Pal S; Sadhu AS; Patra S; Mukherjea KK
J Exp Clin Cancer Res; 2008 Nov; 27(1):68. PubMed ID: 19014472
[TBL] [Abstract][Full Text] [Related]
18. Hepatotoxicity, nephrotoxicity, and drug/chemical interaction toxicity of platinum nanoparticles in mice.
Isoda K; Daibo T; Yushina K; Yoshioka Y; Tsutsumi Y; Akimoto Y; Kawakami H; Taira Y; Taira I; Yanoshita R; Nishimura T; Ishida I
Pharmazie; 2017 Jan; 72(1):10-16. PubMed ID: 29441891
[TBL] [Abstract][Full Text] [Related]
19. Impact of repeated exposure on toxicity of perchloroethylene in Swiss Webster mice.
Philip BK; Mumtaz MM; Latendresse JR; Mehendale HM
Toxicology; 2007 Mar; 232(1-2):1-14. PubMed ID: 17267091
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of fluorenhymustine as a rationally designed novel anticancer agent.
Samanta S; Pain A; Ghosh M; Dutta S; Sanyal U
Exp Oncol; 2005 Dec; 27(4):279-85. PubMed ID: 16404347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
